questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Glycoprotéines membranaires
Glycoprotéines membranaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Glycoprotéines
Biopsie
Tests sanguins
Électrophorèse
Chromatographie
Glycoprotéines
Tests génétiques
Glycoprotéines
Mutations
Antigènes
Glycoprotéines
Marqueurs biologiques
Imagerie médicale
Glycoprotéines
Changements cellulaires
Symptômes
5
Inflammation
Troubles immunitaires
Glycoprotéines
Troubles neurologiques
Glycoprotéines
Maladies neurodégénératives
Éruptions cutanées
Glycoprotéines
Dermatologie
Troubles respiratoires
Glycoprotéines
Fonction pulmonaire
Symptômes digestifs
Glycoprotéines
Troubles gastro-intestinaux
Prévention
5
Prévention
Glycoprotéines
Mode de vie sain
Vaccinations
Glycoprotéines
Infections
Dépistage
Glycoprotéines
Prévention
Habitudes de vie
Glycoprotéines
Santé cellulaire
Éducation à la santé
Glycoprotéines
Prévention
Traitements
5
Thérapie génique
Médicaments immunomodulateurs
Glycoprotéines
Traitements biologiques
Glycoprotéines
Immunothérapie
Nutrition
Glycoprotéines
Fonction cellulaire
Thérapies physiques
Glycoprotéines
Réhabilitation
Médicaments anti-inflammatoires
Glycoprotéines
Inflammation
Complications
5
Complications
Glycoprotéines
Maladies auto-immunes
Complications neurologiques
Glycoprotéines
Troubles neurologiques
Complications cardiovasculaires
Glycoprotéines
Maladies cardiovasculaires
Complications infectieuses
Glycoprotéines
Infections
Complications métaboliques
Glycoprotéines
Troubles métaboliques
Facteurs de risque
5
Facteurs de risque
Glycoprotéines
Génétique
Mode de vie
Glycoprotéines
Santé
Maladies chroniques
Glycoprotéines
Prédisposition
Exposition à des toxines
Glycoprotéines
Toxines
Stress
Glycoprotéines
Santé cellulaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Glycoprotéines membranaires : Questions médicales les plus fréquentes",
"headline": "Glycoprotéines membranaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Glycoprotéines membranaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-03",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Glycoprotéines membranaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines membranaires",
"url": "https://questionsmedicales.fr/mesh/D008565",
"about": {
"@type": "MedicalCondition",
"name": "Protéines membranaires",
"code": {
"@type": "MedicalCode",
"code": "D008565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigène AC133",
"alternateName": "AC133 Antigen",
"url": "https://questionsmedicales.fr/mesh/D000071916",
"about": {
"@type": "MedicalCondition",
"name": "Antigène AC133",
"code": {
"@type": "MedicalCode",
"code": "D000071916",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.023"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD38",
"alternateName": "ADP-ribosyl Cyclase 1",
"url": "https://questionsmedicales.fr/mesh/D051997",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD38",
"code": {
"@type": "MedicalCode",
"code": "D051997",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.045"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD47",
"alternateName": "CD47 Antigen",
"url": "https://questionsmedicales.fr/mesh/D051928",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD47",
"code": {
"@type": "MedicalCode",
"code": "D051928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.147"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD58",
"alternateName": "CD58 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018968",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD58",
"code": {
"@type": "MedicalCode",
"code": "D018968",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.158"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Butyrophilines",
"alternateName": "Butyrophilins",
"url": "https://questionsmedicales.fr/mesh/D000071797",
"about": {
"@type": "MedicalCondition",
"name": "Butyrophilines",
"code": {
"@type": "MedicalCode",
"code": "D000071797",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.195"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines liées au GPI",
"alternateName": "GPI-Linked Proteins",
"url": "https://questionsmedicales.fr/mesh/D058851",
"about": {
"@type": "MedicalCondition",
"name": "Protéines liées au GPI",
"code": {
"@type": "MedicalCode",
"code": "D058851",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD55",
"alternateName": "CD55 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018958",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD55",
"code": {
"@type": "MedicalCode",
"code": "D018958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.130"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigènes CD59",
"alternateName": "CD59 Antigens",
"url": "https://questionsmedicales.fr/mesh/D018957",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD59",
"code": {
"@type": "MedicalCode",
"code": "D018957",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.140"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène stromal-2 de la moëlle osseuse",
"alternateName": "Bone Marrow Stromal Antigen 2",
"url": "https://questionsmedicales.fr/mesh/D000074010",
"about": {
"@type": "MedicalCondition",
"name": "Antigène stromal-2 de la moëlle osseuse",
"code": {
"@type": "MedicalCode",
"code": "D000074010",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Carbonic anhydrase-IV",
"alternateName": "Carbonic Anhydrase IV",
"url": "https://questionsmedicales.fr/mesh/D030741",
"about": {
"@type": "MedicalCondition",
"name": "Carbonic anhydrase-IV",
"code": {
"@type": "MedicalCode",
"code": "D030741",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.160"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glypicanes",
"alternateName": "Glypicans",
"url": "https://questionsmedicales.fr/mesh/D053673",
"about": {
"@type": "MedicalCondition",
"name": "Glypicanes",
"code": {
"@type": "MedicalCode",
"code": "D053673",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 17",
"alternateName": "Matrix Metalloproteinase 17",
"url": "https://questionsmedicales.fr/mesh/D053515",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 17",
"code": {
"@type": "MedicalCode",
"code": "D053515",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uromoduline",
"alternateName": "Uromodulin",
"url": "https://questionsmedicales.fr/mesh/D058949",
"about": {
"@type": "MedicalCondition",
"name": "Uromoduline",
"code": {
"@type": "MedicalCode",
"code": "D058949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418.850"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Glycoprotéines de membrane associées au lysosome",
"alternateName": "Lysosome-Associated Membrane Glycoproteins",
"url": "https://questionsmedicales.fr/mesh/D051907",
"about": {
"@type": "MedicalCondition",
"name": "Glycoprotéines de membrane associées au lysosome",
"code": {
"@type": "MedicalCode",
"code": "D051907",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.527"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine de membrane-2 associée au lysosome",
"alternateName": "Lysosomal-Associated Membrane Protein 2",
"url": "https://questionsmedicales.fr/mesh/D052119",
"about": {
"@type": "MedicalCondition",
"name": "Protéine de membrane-2 associée au lysosome",
"code": {
"@type": "MedicalCode",
"code": "D052119",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.527.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 de membrane associée au lysosome",
"alternateName": "Lysosomal-Associated Membrane Protein 3",
"url": "https://questionsmedicales.fr/mesh/D059666",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 de membrane associée au lysosome",
"code": {
"@type": "MedicalCode",
"code": "D059666",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.527.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Mucine-3",
"alternateName": "Mucin-3",
"url": "https://questionsmedicales.fr/mesh/D055263",
"about": {
"@type": "MedicalCondition",
"name": "Mucine-3",
"code": {
"@type": "MedicalCode",
"code": "D055263",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.542"
}
}
},
{
"@type": "MedicalWebPage",
"name": "PHEX Phosphate regulating neutral endopeptidase",
"alternateName": "PHEX Phosphate Regulating Neutral Endopeptidase",
"url": "https://questionsmedicales.fr/mesh/D053402",
"about": {
"@type": "MedicalCondition",
"name": "PHEX Phosphate regulating neutral endopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D053402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.607"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sarcoglycanes",
"alternateName": "Sarcoglycans",
"url": "https://questionsmedicales.fr/mesh/D049031",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoglycanes",
"code": {
"@type": "MedicalCode",
"code": "D049031",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.712"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndécanes",
"alternateName": "Syndecans",
"url": "https://questionsmedicales.fr/mesh/D053667",
"about": {
"@type": "MedicalCondition",
"name": "Syndécanes",
"code": {
"@type": "MedicalCode",
"code": "D053667",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndécane-1",
"alternateName": "Syndecan-1",
"url": "https://questionsmedicales.fr/mesh/D053668",
"about": {
"@type": "MedicalCondition",
"name": "Syndécane-1",
"code": {
"@type": "MedicalCode",
"code": "D053668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndécane-2",
"alternateName": "Syndecan-2",
"url": "https://questionsmedicales.fr/mesh/D053669",
"about": {
"@type": "MedicalCondition",
"name": "Syndécane-2",
"code": {
"@type": "MedicalCode",
"code": "D053669",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndécane-3",
"alternateName": "Syndecan-3",
"url": "https://questionsmedicales.fr/mesh/D053670",
"about": {
"@type": "MedicalCondition",
"name": "Syndécane-3",
"code": {
"@type": "MedicalCode",
"code": "D053670",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndécane-4",
"alternateName": "Syndecan-4",
"url": "https://questionsmedicales.fr/mesh/D053671",
"about": {
"@type": "MedicalCondition",
"name": "Syndécane-4",
"code": {
"@type": "MedicalCode",
"code": "D053671",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.847.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thrombospondines",
"alternateName": "Thrombospondins",
"url": "https://questionsmedicales.fr/mesh/D019699",
"about": {
"@type": "MedicalCondition",
"name": "Thrombospondines",
"code": {
"@type": "MedicalCode",
"code": "D019699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.895"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thrombospondine-1",
"alternateName": "Thrombospondin 1",
"url": "https://questionsmedicales.fr/mesh/D019700",
"about": {
"@type": "MedicalCondition",
"name": "Thrombospondine-1",
"code": {
"@type": "MedicalCode",
"code": "D019700",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.895.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Uroplakines",
"alternateName": "Uroplakins",
"url": "https://questionsmedicales.fr/mesh/D060165",
"about": {
"@type": "MedicalCondition",
"name": "Uroplakines",
"code": {
"@type": "MedicalCode",
"code": "D060165",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.942"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Uroplakine II",
"alternateName": "Uroplakin II",
"url": "https://questionsmedicales.fr/mesh/D060170",
"about": {
"@type": "MedicalCondition",
"name": "Uroplakine II",
"code": {
"@type": "MedicalCode",
"code": "D060170",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.942.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uroplakine III",
"alternateName": "Uroplakin III",
"url": "https://questionsmedicales.fr/mesh/D060171",
"about": {
"@type": "MedicalCondition",
"name": "Uroplakine III",
"code": {
"@type": "MedicalCode",
"code": "D060171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.942.300"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Glycoprotéines membranaires",
"alternateName": "Membrane Glycoproteins",
"code": {
"@type": "MedicalCode",
"code": "D008562",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yang Liu",
"url": "https://questionsmedicales.fr/author/Yang%20Liu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430207, China."
}
},
{
"@type": "Person",
"name": "Hanh T Nguyen",
"url": "https://questionsmedicales.fr/author/Hanh%20T%20Nguyen",
"affiliation": {
"@type": "Organization",
"name": "Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA."
}
},
{
"@type": "Person",
"name": "Pablo Guardado-Calvo",
"url": "https://questionsmedicales.fr/author/Pablo%20Guardado-Calvo",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France."
}
},
{
"@type": "Person",
"name": "Félix A Rey",
"url": "https://questionsmedicales.fr/author/F%C3%A9lix%20A%20Rey",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France. Electronic address: felix.rey@pasteur.fr."
}
},
{
"@type": "Person",
"name": "Cheng Man Lun",
"url": "https://questionsmedicales.fr/author/Cheng%20Man%20Lun",
"affiliation": {
"@type": "Organization",
"name": "Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Efficacy of lidocaine injection method for esophageal endoscopic submucosal dissection: single-center, double-blind, randomized controlled trial.",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36266483",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00464-022-09716-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial.",
"datePublished": "2023-10-12",
"url": "https://questionsmedicales.fr/article/37839420",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/S0140-6736(23)01572-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cracking double-blind review: Authorship attribution with deep learning.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37390072",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0287611"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neurofeedback for obsessive compulsive disorder: A randomized, double-blind trial.",
"datePublished": "2023-09-03",
"url": "https://questionsmedicales.fr/article/37722238",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychres.2023.115458"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35918311",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41398-022-02039-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Glycoprotéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008562"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Glycoprotéines membranaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Glycoprotéines membranaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Glycoprotéines membranaires",
"description": "Comment diagnostiquer une anomalie des glycoprotéines membranaires ?\nQuels tests sont utilisés pour évaluer les glycoprotéines ?\nLes tests génétiques sont-ils utiles pour les glycoprotéines ?\nQuels marqueurs sont associés aux glycoprotéines ?\nLes imageries médicales aident-elles au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Double-Blind+Method#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Glycoprotéines membranaires",
"description": "Quels symptômes indiquent un problème de glycoprotéines ?\nLes troubles neurologiques sont-ils liés aux glycoprotéines ?\nPeut-on observer des symptômes cutanés ?\nLes troubles respiratoires sont-ils associés aux glycoprotéines ?\nLes symptômes digestifs peuvent-ils être liés ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Double-Blind+Method#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Glycoprotéines membranaires",
"description": "Comment prévenir les troubles liés aux glycoprotéines ?\nLes vaccinations sont-elles importantes ?\nLe dépistage précoce est-il recommandé ?\nLes habitudes de vie influencent-elles la santé des glycoprotéines ?\nL'éducation à la santé est-elle cruciale ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Double-Blind+Method#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Glycoprotéines membranaires",
"description": "Quels traitements ciblent les anomalies glycoprotéiques ?\nLes traitements biologiques sont-ils efficaces ?\nLa nutrition joue-t-elle un rôle dans le traitement ?\nLes thérapies physiques sont-elles bénéfiques ?\nLes médicaments anti-inflammatoires sont-ils utilisés ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Double-Blind+Method#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Glycoprotéines membranaires",
"description": "Quelles complications peuvent survenir avec des anomalies glycoprotéiques ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications cardiovasculaires sont-elles possibles ?\nLes complications infectieuses sont-elles liées ?\nLes complications métaboliques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Double-Blind+Method#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Glycoprotéines membranaires",
"description": "Quels facteurs de risque sont associés aux anomalies glycoprotéiques ?\nLe mode de vie influence-t-il les glycoprotéines ?\nLes maladies chroniques sont-elles un facteur de risque ?\nL'exposition à des toxines est-elle un risque ?\nLe stress a-t-il un impact sur les glycoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D008562?mesh_terms=Double-Blind+Method#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des glycoprotéines membranaires ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies peuvent révéler des anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les glycoprotéines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électrophorèse et la chromatographie sont couramment utilisés pour l'évaluation."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les glycoprotéines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant les glycoprotéines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux glycoprotéines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme les antigènes peuvent indiquer des anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Les imageries médicales aident-elles au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines imageries peuvent montrer des changements cellulaires liés aux glycoprotéines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de glycoprotéines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'inflammation ou des troubles immunitaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés aux glycoprotéines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines glycoprotéines sont impliquées dans des maladies neurologiques."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes cutanés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent être liées à des anomalies des glycoprotéines."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils associés aux glycoprotéines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines glycoprotéines peuvent affecter la fonction pulmonaire et causer des troubles."
}
},
{
"@type": "Question",
"name": "Les symptômes digestifs peuvent-ils être liés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies glycoprotéiques peuvent entraîner des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux glycoprotéines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces troubles."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections affectant les glycoprotéines."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage peut aider à identifier les anomalies glycoprotéiques tôt."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles la santé des glycoprotéines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes saines peuvent améliorer la santé cellulaire et glycoprotéique."
}
},
{
"@type": "Question",
"name": "L'éducation à la santé est-elle cruciale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sensibiliser à la santé peut aider à prévenir les troubles liés aux glycoprotéines."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les anomalies glycoprotéiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des médicaments immunomodulateurs peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements biologiques sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements biologiques peuvent cibler spécifiquement les glycoprotéines."
}
},
{
"@type": "Question",
"name": "La nutrition joue-t-elle un rôle dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en nutriments peut soutenir la fonction des glycoprotéines."
}
},
{
"@type": "Question",
"name": "Les thérapies physiques sont-elles bénéfiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent aider à améliorer la fonction cellulaire et réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Les médicaments anti-inflammatoires sont-ils utilisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire l'inflammation liée aux anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies glycoprotéiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des maladies auto-immunes ou des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent être des complications des anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles possibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies glycoprotéiques peuvent augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications infectieuses sont-elles liées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies glycoprotéiques peuvent rendre les cellules plus vulnérables aux infections."
}
},
{
"@type": "Question",
"name": "Les complications métaboliques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies glycoprotéiques peuvent entraîner des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux anomalies glycoprotéiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, la génétique et l'environnement peuvent influencer les anomalies."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il les glycoprotéines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut augmenter le risque d'anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies chroniques peuvent prédisposer à des anomalies glycoprotéiques."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines peut affecter la structure des glycoprotéines."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les glycoprotéines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut influencer la fonction des glycoprotéines et la santé cellulaire."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430207, China.
Publications dans "Glycoprotéines membranaires" :
3 publications dans cette catégorie
Affiliations :
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France. Electronic address: felix.rey@pasteur.fr.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA efreed@nih.gov.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
NIH Center for Macromolecular Modeling and Bioinformatics, Beckman Institute for Advanced Science and Technology, Department of Biochemistry, Center for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign Urbana IL 61801 USA emad@illinois.edu.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States.
Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430207, China; University of the Chinese Academy of Sciences, Beijing, 100049, China.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430207, China; University of the Chinese Academy of Sciences, Beijing, 100049, China.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430207, China; University of the Chinese Academy of Sciences, Beijing, 100049, China. Electronic address: wangwei@wh.iov.cn.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, 86-710032, PR China.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, 86-710032, PR China.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, 86-710032, PR China.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, 86-710032, PR China. Electronic address: superjames1991@foxmail.com.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, 86-710032, PR China. Electronic address: yangkunkun@fmmu.edu.cn.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Naval Medical University, 325 Guohe Road, Shanghai 200433, China.
Publications dans "Glycoprotéines membranaires" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Naval Medical University, 325 Guohe Road, Shanghai 200433, China.
Publications dans "Glycoprotéines membranaires" :
Intraoperative body movements are one of the causes of difficulty in performing esophageal endoscopic submucosal dissection (ESD) under conscious sedation. The use of local anesthetics as local inject...
This was a single-center, prospective, double-blind, randomized trial. Patients who underwent esophageal ESD under conscious sedation from June 2018 to May 2021 were included in this study. In the LIM...
Fifty patients were enrolled and randomized in a 1:1 ratio in two groups. The incidence of body movements was significantly lower in the LIM group (12% [3/25]) than in the control group (48% [12/25]; ...
LIM during esophageal ESD reduced body movements while decreasing the level of sedation. Therefore, LIM during esophageal ESD is an option for maintaining good sedation (UMIN000032804)....
Hand osteoarthritis is a disabling condition with few effective therapies. Hand osteoarthritis with synovitis is a common inflammatory phenotype associated with pain. We aimed to examine the efficacy ...
In this multisite, parallel-group, double-blind, randomised, placebo-controlled trial, participants (aged 40-75 years) with hand osteoarthritis (Kellgren and Lawrence grade ≥2 in at least one joint) a...
Between Nov 22, 2017, and Nov 8, 2021, of 202 participants who were assessed for eligibility, 97 (48%) were randomly assigned to receive methotrexate (n=50) or placebo (n=47). 68 (70%) of 97 participa...
Treatment of hand osteoarthritis and synovitis with 20 mg methotrexate for 6 months had a moderate but potentially clinically meaningful effect on reducing pain, providing proof of concept that methot...
National Health and Medical Research Council of Australia....
Double-blind peer review is considered a pillar of academic research because it is perceived to ensure a fair, unbiased, and fact-centered scientific discussion. Yet, experienced researchers can often...
We aim to develop fMRI neurofeedback as a treatment for obsessive compulsive disorder (OCD). In prior work, we found that providing neurofeedback of activity in the anterior prefrontal cortex (aPFC) i...
The use of low sub-perceptual doses of psychedelics ("microdosing") has gained popularity in recent years. Although anecdotal reports claim multiple benefits associated with this practice, the lack of...
Autism spectrum disorder (ASD) is a pervasive neurodevelopmental disorder with repetitive behaviour which affects interaction and communication. Sulforaphane (SFN), an isothiocyanate abundant in the s...
Geraniol is an acyclic monoterpene alcohol with well-known anti-inflammatory and antimicrobial properties which has shown eubiotic activity towards gut microbiota (GM) in patients with irritable bowel...
Fifty-six IBS patients diagnosed according to Rome III criteria were enrolled in an interventional, prospective, multicentric, randomized, double-blinded, placebo-controlled trial. In the treatment ar...
Patients treated with LAGS showed a significant reduction in their IBS symptoms severity score (IBS-SSS) compared to the placebo (195 vs. 265,...
LAGS was effective in treating overall IBS symptoms, together with an improvement in the gut microbiota profile, especially for the IBS mixed subtype....
Double-blinding subjects to the experiment's purpose is an important standard in neurofeedback studies. However, it is difficult to provide evidence that humans are entirely unaware of certain informa...
Double-blind, placebo-controlled food challenge (DBPCFC) remains the gold standard for diagnosing food allergy, despite sparse comparisons to open food challenges (OpenFCs). The objective of this retr...
This study included patients from the Allergy Centre, Odense University Hospital with a positive oral food challenge, defined as strict objective signs, with peanut during the period 2001-2022. Severi...
In total, 318 positive OpenFCs and 86 DBPCFCs were included. There was no difference in severity of symptoms nor threshold values comparing the two challenge types, neither when stratified for age gro...
Our findings do not advocate for DBPCFC being superior to OpenFC, if the latter is performed with strict objective stop criteria by trained staff....
Probiotics are considered safe and beneficial to human health. However, the safety of...